329 related articles for article (PubMed ID: 24862144)
1. Risk factors for venous thromboembolism in cancer: novel findings from the Vienna Cancer and Thrombosis Study (CATS).
Königsbrügge O; Pabinger I; Ay C
Thromb Res; 2014 May; 133 Suppl 2():S39-43. PubMed ID: 24862144
[TBL] [Abstract][Full Text] [Related]
2. Predictive potential of haemostatic biomarkers for venous thromboembolism in cancer patients.
Ay C; Pabinger I
Thromb Res; 2012 Apr; 129 Suppl 1():S6-9. PubMed ID: 22682135
[TBL] [Abstract][Full Text] [Related]
3. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
Ay C; Vormittag R; Dunkler D; Simanek R; Chiriac AL; Drach J; Quehenberger P; Wagner O; Zielinski C; Pabinger I
J Clin Oncol; 2009 Sep; 27(25):4124-9. PubMed ID: 19636003
[TBL] [Abstract][Full Text] [Related]
4. Association of mean platelet volume with risk of venous thromboembolism and mortality in patients with cancer. Results from the Vienna Cancer and Thrombosis Study (CATS).
Riedl J; Kaider A; Reitter EM; Marosi C; Jäger U; Schwarzinger I; Zielinski C; Pabinger I; Ay C
Thromb Haemost; 2014 Apr; 111(4):670-8. PubMed ID: 24306221
[TBL] [Abstract][Full Text] [Related]
5. Association Between Decreased Serum Albumin With Risk of Venous Thromboembolism and Mortality in Cancer Patients.
Königsbrügge O; Posch F; Riedl J; Reitter EM; Zielinski C; Pabinger I; Ay C
Oncologist; 2016 Feb; 21(2):252-7. PubMed ID: 26764252
[TBL] [Abstract][Full Text] [Related]
6. Tumor grade is associated with venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
Ahlbrecht J; Dickmann B; Ay C; Dunkler D; Thaler J; Schmidinger M; Quehenberger P; Haitel A; Zielinski C; Pabinger I
J Clin Oncol; 2012 Nov; 30(31):3870-5. PubMed ID: 23008313
[TBL] [Abstract][Full Text] [Related]
7. Hemostatic Biomarkers and Venous Thromboembolism Are Associated With Mortality and Response to Chemotherapy in Patients With Pancreatic Cancer.
Moik F; Prager G; Thaler J; Posch F; Wiedemann S; Schramm T; Englisch C; Mackman N; Pabinger I; Ay C
Arterioscler Thromb Vasc Biol; 2021 Nov; 41(11):2837-2847. PubMed ID: 34470475
[TBL] [Abstract][Full Text] [Related]
8. Tests predictive of thrombosis in cancer.
Ay C; Pabinger I
Thromb Res; 2010 Apr; 125 Suppl 2():S12-5. PubMed ID: 20433990
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers and venous thromboembolism.
Pabinger I; Ay C
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):332-6. PubMed ID: 19228607
[TBL] [Abstract][Full Text] [Related]
10. Soluble Vascular Endothelial Growth Factor (sVEGF) and the Risk of Venous Thromboembolism in Patients with Cancer: Results from the Vienna Cancer and Thrombosis Study (CATS).
Posch F; Thaler J; Zlabinger GJ; Königsbrügge O; Koder S; Zielinski C; Pabinger I; Ay C
Clin Cancer Res; 2016 Jan; 22(1):200-6. PubMed ID: 26302981
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers for prediction of venous thromboembolism in cancer.
Pabinger I; Thaler J; Ay C
Blood; 2013 Sep; 122(12):2011-8. PubMed ID: 23908470
[TBL] [Abstract][Full Text] [Related]
12. Association of platelet activation markers with cancer-associated venous thromboembolism.
Riedl J; Hell L; Kaider A; Koder S; Marosi C; Zielinski C; Panzer S; Pabinger I; Ay C
Platelets; 2016; 27(1):80-5. PubMed ID: 25970326
[TBL] [Abstract][Full Text] [Related]
13. Presence of varicose veins in cancer patients increases the risk for occurrence of venous thromboembolism.
Königsbrügge O; Lötsch F; Reitter EM; Brodowicz T; Zielinski C; Pabinger I; Ay C
J Thromb Haemost; 2013 Nov; 11(11):1993-2000. PubMed ID: 24112869
[TBL] [Abstract][Full Text] [Related]
14. High factor VIII levels independently predict venous thromboembolism in cancer patients: the cancer and thrombosis study.
Vormittag R; Simanek R; Ay C; Dunkler D; Quehenberger P; Marosi C; Zielinski C; Pabinger I
Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2176-81. PubMed ID: 19778945
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal analysis of hemostasis biomarkers in cancer patients during antitumor treatment.
Reitter EM; Kaider A; Ay C; Quehenberger P; Marosi C; Zielinski C; Pabinger I
J Thromb Haemost; 2016 Feb; 14(2):294-305. PubMed ID: 26662117
[TBL] [Abstract][Full Text] [Related]
16. Venous thromboembolism: risk factors for recurrence.
Zhu T; Martinez I; Emmerich J
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
[TBL] [Abstract][Full Text] [Related]
17. Elevated white blood cell count and outcome in cancer patients with venous thromboembolism. Findings from the RIETE Registry.
Trujillo-Santos J; Di Micco P; Iannuzzo M; Lecumberri R; Guijarro R; Madridano O; Monreal M;
Thromb Haemost; 2008 Nov; 100(5):905-11. PubMed ID: 18989537
[TBL] [Abstract][Full Text] [Related]
18. Red cell distribution width and other red blood cell parameters in patients with cancer: association with risk of venous thromboembolism and mortality.
Riedl J; Posch F; Königsbrügge O; Lötsch F; Reitter EM; Eigenbauer E; Marosi C; Schwarzinger I; Zielinski C; Pabinger I; Ay C
PLoS One; 2014; 9(10):e111440. PubMed ID: 25347577
[TBL] [Abstract][Full Text] [Related]
19. High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS).
Simanek R; Vormittag R; Ay C; Alguel G; Dunkler D; Schwarzinger I; Steger G; Jaeger U; Zielinski C; Pabinger I
J Thromb Haemost; 2010 Jan; 8(1):114-20. PubMed ID: 19889150
[TBL] [Abstract][Full Text] [Related]
20. The role of fibrinogen plasma levels, the -455G>A fibrinogen and the factor XIII A subunit (FXIII-A) Val34Leu polymorphism in cancer-associated venous thrombosis.
Tiedje V; Dunkler D; Ay C; Horvath B; Quehenberger P; Pabinger M; Zielinski C; Pabinger I; Mannhalter C
Thromb Haemost; 2011 Nov; 106(5):908-13. PubMed ID: 21901234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]